Trials / Completed
CompletedNCT06268912
Cryoanalgesia for Irreversible Pulpitis
Cryoanalgesia: Temperature Modulation for Pain Management in Irreversible Pulpitis a Randomized Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Universitat Internacional de Catalunya · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the present study was to evaluate the effectiveness of pulpal anesthesia in pain control during endodontic treatment by lowering the temperature of the injected plain 3% cold Mepivacaine (5ºC) compared to 3% Mepivacaine at room temperature in teeth with irreversible pulpitis.
Detailed description
Mepivacaine has some advantages over other anesthetics. The investigators wanted to compare whether changing temperature could improve its effectiveness in cases of irreversible pulpitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Cold Mepivacaine | change the temperature, 3% at 5ºC |
| PROCEDURE | Mepivacaine at room temperature | no change the temperature of anesthesia |
Timeline
- Start date
- 2022-09-07
- Primary completion
- 2023-09-07
- Completion
- 2024-01-07
- First posted
- 2024-02-20
- Last updated
- 2024-02-20
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06268912. Inclusion in this directory is not an endorsement.